News in Brief

Stax to the mAx? Pall launches single-use mAb harvesting tech

By Staff Reporter

- Last updated on GMT

GettyImages/media point inc
GettyImages/media point inc

Related tags Biotechnology Cell biology

Pall Corporation has launched a monoclonal antibody clarification platform without centrifugation or process additives to support cell cultures of up to 2,000L.

The Stax mAx clarification technology is a single-use monoclonal antibody harvesting platform consisting of two double-layer depth filtration grades – PDP8 plus PDE2 – which combine to create a 4-layer depth filter system.

According to the life sciences firm, the tech is a high throughput offering which can achieve an economic depth filtration solution with cell culture volumes of up to 2,000L.

“As cell densities increase, demand has grown for less challenging, more economical—both footprint and cost-wise—clarification solutions,”​ Mario Philips, VP and GM of Pall Life Sciences said in a statement.

“The Stax mAx clarification platform was born from Pall's legacy strength in filtration, and leverages our proven Stax single-use capsule system. This latest addition to our portfolio, once again, reflects our commitment to delivering innovative total solutions to our customers.”

Related news

Show more

Related products

show more

eBook: mRNA prospects and scale-up solutions

eBook: mRNA prospects and scale-up solutions

Thermo Fisher Scientific - Biosciences | 22-Mar-2023 | Insight Guide

This mRNA eBook was created by Thermo Fisher Scientific, in collaboration with Genetic Engineering & Biotechnology News (GEN), to provide you with...

Create Better Biologic Treatments with Catalent

Create Better Biologic Treatments with Catalent

Catalent | 21-Feb-2023 | Product Brochure

Deliver safe and stable products to your patients with the help of Catalent Biologics' Limoges, France site, a European Center of Excellence for early-phase...

Related suppliers

Follow us


View more